← Open Payments lookup

KIMBERLY NOVENSKI: Open Payments

NPI 1831817477 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,623 in 125 payments from 18 companies in 2025. Trend: 2023 $3,842 · 2024 $2,682 · 2025 $3,623

Food & beverage: $3,623
CompanyPaymentsAmount
Amgen Inc.24$799
E.R. Squibb & Sons, L.L.C.18$476
AstraZeneca Pharmaceuticals LP6$441
Novartis Pharmaceuticals Corporation15$255
Edwards Lifesciences Corporation2$224
Boehringer Ingelheim Pharmaceuticals, Inc.5$212
Novo Nordisk Inc5$208
Esperion Therapeutics, Inc.14$169
Boston Scientific Corporation2$155
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)8$150

Products named: REPATHA, CAMZYOS, LOKELMA, LEQVIO, SAPIEN 3 Ultra RESILIA, JARDIANCE, NEXLETOL, WATCHMAN FLX.

Industry payments across AZ — which companies pay providers there.